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Abstract
Thalidomide is an oral drug marketed in the 1950s as a sedative and an anti-emetic during pregnancy that was
removed from the market when its teratogenic side effects appeared in new born children due to inadequate tests to
assess the drug4s safety. Recent studies evaluating the use of thalidomide in cancer and HIV diseases have sparked
renewed interest. The electrochemical behavior of thalidomide on a glassy carbon electrode has been investigated
using cyclic, differential and square-wave voltammetry in aqueous media at different pHs. The oxidation mechanism
of thalidomide is an irreversible, adsorption-controlled process, pH dependent up to values close to the pKa and
occurs in two consecutive charge transfer reactions. A mechanism of oxidation of thalidomide involving one electron
and one proton to produce a cation radical, which reacts with water and yields a final hydroxylated product is
proposed. The reduction of thalidomide is also a pH dependent, irreversible process and occurs in a single step, with
the same number of electrons and protons transferred. The reduction mechanism involves the protonation of the
nitrogen that bridges the two cyclic groups, and the product of the protonation reaction causes irreversible
dissociation. Both thalidomide and the non electroactive oxidation and reduction products are strongly adsorbed on
the glassy carbon electrode surface.
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1. Introduction
Originally developed in the 19504s, as a sedative and anti-
emetic drug to combat morning sickness during pregnancy,
thalidomide (TD) [1,3-dioxo-2-(2’,6’-dioxopiperidin-3-y1)-
isoindol or ( )-phthalimidoglutarimide] (Scheme 1) was
removed from the market when its teratogenic side effects,
best described as heavy dysmelia (stunted limb growth),
appeared in new born children shortly after its introduction.
In fact, inadequate testswereperformedbefore its release to
assess the drug4s safety, with catastrophic results for the
children of women who had taken thalidomide during their
pregnancies. In recent years, TD has regained scientific
interest because of its potential for treating a number of
otherwise intractable inflammatory skin diseases (erythema
nodosum leprosum – ENL a complication of leprosy, graft
versus host disease), weight loss in tuberculosis, aphthous
ulcers, wasting, human immunodeficiency virus replication
in acquired immune deficiency syndrome and cancer [1 – 3].
TD is only sparingly soluble in aqueous solution (ca.
0.012 mg mL1), and attempts to solubilize TD in organic
solvents did not lead to therapeutic applications [4] and
references therein. Biological experiments with poorly
soluble drugs such as TD are seldom reproducible and
have often led to misinterpretation. Precipitation leads to
unreliable biological results. Consequently the in vivo
mechanism of action of TD is not yet fully understood but
there is some evidence suggesting that TD requires cyto-
chrome P450 (CYP)-catalyzed biotransformation to exert
its pharmacological activity. This activity includes inhibition
of cellular adhesion, alternation of cell morphology and
differentiation, and anti-angiogenesis. The main in vivo
transformation is spontaneous nonenzymatic hydrolysis, but
this pathway does not appear to be responsible for TD
activity [5 – 7].
The oxidation of TD by CYP2C19 producing 5-hydroxy-
thalidomide and 5’-hydroxythalidomide metabolites has
been reported, and these oxidation products have also been
isolated in patient4s plasma and urine; 5-hydroxythalido-
mide (5-OH), by hydroxylation of the phthalidomide ring
possible via arene oxides, and cis- and trans-5’-hydroxytha-
lidomide (5’-OH), by hydroxylation of the glutarimide ring.Scheme 1. Chemical structure of TD.
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Studies have shown that this biotransformation is stereose-
lective, with (S)-()-thalidomide preferentially forming
5-OH and (R)-()-thalidomide preferentially forming
trans-5’-hydroxythalidomide which epimerizes spontane-
ously to give the more stable cis- isomer [5 – 7].
On theotherhand, in termsofTDteratogenicitymore than
30 hypotheses have been proposed. They include hydroxyl
radical mediated inhibition of angiogenesis in embryoid
bodies, inhibition of growth factors, intercalation with DNA
synthesis as well as oxidative damage of DNA [2, 4, 8].
Investigations of the redox behavior of biologically
occurring compounds by means of electrochemical tech-
niques have the potential for providing valuable insights
into biological redox reactions of these molecules. Due to
their high sensitivity voltammetric methods were used to
study the redox behavior of various biological compounds
[9 – 15]. The electrochemical reduction behavior of TD has
been studied by polarography at the hanging mercury drop
electrode [13 – 15], but its electrochemical oxidation behav-
ior has never been investigated.
In this paper, the electrochemical oxidation and reduction
mechanisms of TD hydrate, for a wide range of solution
conditions, using cyclic, differential pulse and square-wave
voltammetry, at a glassy carbon electrodewere investigated.
Information on the electrochemical behavior of TD ob-
tained from the results at different pHs may play a crucial
role in understanding its properties as well as its metabolism
in biological system.
2. Experimental
2.1. Materials and Reagents
( )-Thalidomide was obtained from Sigma and used
without further purification. Saturated aqueous solutions
of TD were prepared by shaking about 30 mg of the
compound with 5mL of buffer supporting electrolyte and
filtering. The filtered supernatant was used for the voltam-
metric experiments. All supporting electrolyte buffer sol-
utions, Table 1, were prepared using analytical grade
reagents and purified water from aMilliporeMilli-Q system
(conductivity 0.1 mS cm1).
Nitrogen saturated solutions were obtained by bubbling
high purity N2 for a minimum of 10 minutes in the solution
and continuing with a flow of pure gas over the solution
during the voltammetric experiments.
Microvolumes were measured using EP-10 and EP-100
PlusMotorizedMicroliter Pippettes (Rainin InstrumentCo.
Inc., Woburn, USA). The pH measurements were carried
out with a Crison micropH 2001 pH-meter with an Ingold
combined glass electrode. All experiments were done at
room temperature (25 1 8C).
2.2. Voltammetric Parameters and Electrochemical Cells
Voltammetric experiments were carried out using a mAuto-
lab running with GPES 4.9 software, Eco-Chemie, Utrecht,
The Netherlands. Measurements were carried out using a
glassy carbon electrode (GCE) (d¼ 1.5 mm) working
electrode, a Pt wire counter electrode, and an Ag/AgCl
(3 M KCl) as reference, in a 0.5 mL one-compartment
electrochemical cell. The experimental conditions for differ-
ential pulse voltammetry were: pulse amplitude 50 mV,
pulse width 70 ms, scan rate 5 mV s1. For square-wave
voltammetry the experimental conditions were frequency
25 Hz and potential increment 2 mV, corresponding to an
effective scan rate 100 mV s1.
TheGCEwas polished using diamond spray (particle size
1 mm) before every electrochemical assay. After polishing,
the electrode was rinsed thoroughly with Milli-Q water.
Following thismechanical treatment, theGCEwasplaced in
buffer supporting electrolyte and various differential pulse
voltammograms were recorded until a steady state baseline
voltammogram was obtained. This procedure ensured very
reproducible experimental results.
2.3. Acquisition and Presentation of Voltammetric Data
All differential pulse voltammograms presented were back-
ground-subtracted and baseline-corrected using themoving
average application with a step window of 5 mV included in
GPES version 4.9 software. This mathematical treatment
improves the visualization and identification of peaks over
the baseline without introducing any artifact, although the
peak current is in some cases reduced (<10%) relative to
that of the untreated curve. Nevertheless, this mathematical
treatment of the original voltammograms was used in the
presentation of all experimental voltammograms for a
better and clearer identification of the peaks. The values
for peak current presented in all graphs were determined
from the original untreated voltammograms after subtrac-
tion of the base line.
3. Results and Discussion
The voltammetric behavior of TD at a GCE was inves-
tigated using cyclic voltammetry, in pH 7 0.1 M phosphate
Table 1. Supporting electrolytes, 0.2 M ionic strength.
pH Composition
2.2 HClþKCl
3.4 HAcOþNaAcO
4.5 HAcOþNaAcO
5.3 HAcOþNaAcO
6.1 NaH2PO4þNa2HPO4
7.0 NaH2PO4þNa2HPO4
8.1 NaH2PO4þNa2HPO4
9.3 NaOHþNa2B2O7
11.1 NaOHþKCl
12.8 NaOHþKCl
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buffer N2 saturated, supporting electrolyte (Fig. 1). TD
solubility in aqueous solution (ca. 0.012 mg mL1) is very
low and the supernatant from a saturated solution prepared
directly in buffer supporting electrolyte and filtrated was
always used. Three peaks are observed in Figure 1, one
corresponding to the reduction and two to the oxidation of
TD. However, the oxidation and reduction mechanisms are
independent of each other andwere investigated separately.
3.1. Oxidation
3.1.1. Cyclic Voltammetry
The oxidation of TD at a GCE was studied using the
supernatant from a TD saturated solution prepared directly
in pH 7 0.1 M phosphate buffer supporting electrolyte and
filtered. The cyclic voltammogramobtained at scan rate n¼
100 mV s1 (Fig. 2) show two well-separated consecutive
oxidation peaks. Both peak 1a, at E1pa¼þ0.74 V, and peak
2a, at E2pa¼þ1.10 V, are irreversible. In the second scan a
decrease of peak 1a current and the absence of peak 2a due to
strong adsorption of TD and its oxidation products on the
CGE surface was observed.
Cyclic voltammograms were also obtained for different
scan rates (Fig. 2). Increasing the scan rate, the peak 1a
current also increases, but therewas not a linear relationship
between Ipa of peak 1a and the square root of the scan rate, as
expected for an irreversible diffusion-controlled oxidation
process. This is explained taking into consideration the
strong adsorption of TD molecules and/or their oxidation
products on the GCE surface.
3.1.2. Differential Pulse Voltammetry
Theeffect of pHon the electrochemical oxidation ofTDwas
studied over a wide pH range between 3 and 12 using
differential pulse voltammetry. The voltammograms
(Fig. 3A) were all recorded in solutions of TD prepared
directly in different electrolytes of 0.2 M ionic strength and
filtered.
Only one peak 1a occurs in all supporting electrolytes. For
buffer solutions between pH 3 and 9, the potential of peak 1a
is displaced to more negative values with increasing pH
(Fig. 3A). The slope of the dotted line, 59 mV per pH unit,
shows that the mechanism of this oxidation process in
aqueous media involves the same number of electrons and
protons (Fig. 3B). The number of electrons transferred, n,
was determined by the peak width at half height W1/2
90 mV, and is close to the theoretical value of 90 mV,
corresponding to an electrochemical reaction involving the
transfer of one electron [16]. Consequently, it can be
concluded that oxidation process occurs with the transfer
of one electron and one proton.
For pH> 9, the oxidation potential of peak 1a is inde-
pendent of pH (Fig. 3B), a mechanism involving only 1
electron, with the TD oxidation product possible under-
going chemical deprotonation in alkaline electrolytes [17].
However, for pH> 5 a new peak 2a appeared (Fig. 3A).
The oxidation potential of the peak 2a is also pH dependent
between 6 and 9 and its potential decreases with increasing
pH (Fig. 3B). The slope of the dotted line, 59 mV per pH
unit, shows that the mechanism of this second oxidation
process in aqueous media also involves the same number of
electrons and protons. Taking into consideration that the
width at half height of TD oxidation peak 2a was W1/2
70 mV, the oxidation process involves the transfer of one
electron and one proton.
The importance of TD ionization in the in vitro prediction
of in vivo absorption has been discussed. The role of pKa on
absorption is important, since this is often related to its
effect on lipophilicity and solubility [18]. In order to
measure pKa values, it is necessary to investigate the analyte
indifferent pHenvironments and tomonitor the variationof
potential as a function of the ionization state of the
molecule. The value of pKa 9 for TD was determined
from data in Figure 3B.
Fig. 1. Cyclic voltammogram of TD in pH 7 0.1 M phosphate
buffer, saturated with N2, n¼ 100 mV s1.
Fig. 2. Cyclic voltammograms of TD in pH 7 0.1 M phosphate
buffer at scan rates: 25, 50, 100, and 200 mV s1.
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The variation of peaks 1a and 2a current versus pH shows
that the current increases with the pH (Fig. 3A), reaching a
maximum in pH 7 0.2 M phosphate buffer, and this electro-
lyte was used for further studies.
3.1.3. Square-Wave Voltammetry
The advantages of square-wave voltammetry are greater
speed of analysis, lower consumption of the electroactive
species in relation with differential pulse voltammetry, and
reduced problems with the poisoning of the electrode
surface [16].
The square-wave voltammograms recorded in TD solu-
tions in different electrolytes showed similar features to the
differential pulse voltammograms, i.e., the oxidation peak 1a
in all buffer supporting electrolytes and the appearance of
peak 2a for buffer supporting electrolytes with pH> 5, (not
shown).
A greater advantage of square-wave voltammetry is the
possibility to see during only one scan if the electron transfer
reaction is reversible or not. Since the current is sampled in
both positive and negative-going pulses, peaks correspond-
ing to the oxidation and reduction of the electroactive
species at the electrode surface can be obtained in the same
experiment. Therefore, the irreversibility of both peaks 1a
and 2a was confirmed by plotting the forward and backward
components of the total current obtained in a solution of TD
prepared directly in pH 7 0.1 M phosphate buffer (Fig. 4).
Whereas the forward component showed both peaks at
similar potentials as found by differential pulse voltamme-
try and the same total current was obtained, the backward
component showed no cathodic peak.
Based on the results described a mechanism for the
oxidation of TD in pH 7 0.2 Mphosphate buffer is proposed
(Scheme 2), which in agreement with the TD data obtained
using other methodologies [5, 6, 19 – 23]. In both oxidation
steps one-electron transfer is involved, followed by depro-
tonation to produce a cation radical, which reacts withwater
and yields the final hydroxylated product.
In the first step, peak 1a, one electron is removed from the
phthalidomide ring, following deprotonation and the direct
nucleophilic attack by water with the production of the
5-hydroxythalidomide. In the second step, peak 2a, one
electron is removed from the glutarimide ring, followed also
bydeprotonation and thedirect nucleophilic attackbywater
with the production of 5,5’-hydroxythalidomide.
3.2. Reduction
3.2.1. Cyclic Voltammetry
The reduction of TD at a GCE was studied, due to the low
solubility of TD, using the filtered supernatant from a
saturated solution of a 1.1 mg mL1 prepared directly in
pH 4.5 0.1 M acetate buffer supporting electrolyte. Cyclic
voltammograms of TD solutions, saturated with N2, show
only one reduction peak 3c, at Epc¼ 0.95 V (Fig. 5), in
agreement with previous results obtained with the hanging
mercury drop electrode [13 – 15]. Scanning in the positive
direction, no oxidation peak was observed, showing that the
Fig. 3. A) 3D plot of oxidation background-subtracted differ-
ential pulse voltammograms obtained in TD solution as a function
of pH. B) Plot of (&) Epa of peak 1a and (~) Epa of peak 2a vs. pH.
Dotted line corresponds to 59 mV per pH unit.
Fig. 4. Square-wave voltammogram of TD in pH 7 0.1 M phos-
phate buffer: It – total, If – forward, and Ib – backward, neffective¼
100 mV s1.
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reduction of TD in aqueousmedia is an irreversible process.
A decrease of the reduction current occurs on successive
scans due to adsorption on the GCE surface but the
reduction products are not electroactive.
3.2.2. Differential Pulse Voltammetry
Theelectrochemical reduction ofTDwas also studied over a
wide pH range between 2 and 12 using differential pulse
voltammetry. The differential pulse voltammograms
(Fig. 6A) were all recorded in solutions of TD prepared
directly in different electrolytes of 0.2 M ionic strength,
filtered and saturated with N2. During the voltammetric
measurements a constant flux of N2 was kept over the
solution surface in order to avoid the diffusion of atmos-
pheric oxygen into the solution of TD.
It was observed that peak 3c occurs only in electrolytes
with pH< 9. The potential of peak 3c is displaced to more
negative values with increasing pH. The dependence is
linear over the whole pH range between 2 and 7 (Fig. 6B).
The slope of the dotted line, 59 mV per pH unit, shows that
the same number of electrons and protons is involved in the
reduction mechanism of TD. The width at half-height of
Fig. 5. Cyclic voltammograms of TD in pH 4.5 0.1 M acetate
buffer, N2 saturated: (—) first and ( · · · · · · ) second scan, n ¼
100 mV s1.
Fig. 6. A) 3D plot of reduction background-subtracted differ-
ential pulse voltammograms obtained in TD solution as a function
of pH. B) Plot of Epc of peak 3c vs. pH. Dotted line corresponds to
59 mV per pH unit.
Scheme 2. Proposed oxidation mechanism of TD in pH 7.
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peak 3cwasW1/2 70 mV, so the reductionofTDoccurswith
one electron and one proton transfer.
The cathodic peak 3c, Epc¼0.95 V, involves the proto-
nation of the nitrogen that bridges the two cyclic groups, and
the product of the reaction with onemore proton causes the
irreversible dissociation of TD.
4. Conclusions
The study shows that TD, a molecule with a large range of
applications in biological and clinical activity, undergoes
oxidation and reduction at a glassy carbon electrode.
The oxidation of TD is an irreversible adsorption-
controlled process, pH dependent and occurs in two steps,
leading to the formation of non electroactive oxidation
products that strongly adsorb on the GCE surface. Both
oxidation steps involve one electron- and one proton
transfer to produce a cation radical, which reacts with water
and yields the final hydroxylated product.
The reduction of TD is also an irreversible, pH dependent
process and occurs in a single step, with the same number of
electrons and protons transfer, leading to the formation of a
non electroactive reduction product that strongly adsorbs
on theGCE surface. The reduction involves the protonation
of the nitrogen that bridges the two cyclic groups, and the
product of the protonation reaction causes the irreversible
dissociation of TD.
The electroanalytical determination of TD in biological
fluids is foreseen and would provide very important and
useful data for clinicians.
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